{
    "organizations": [],
    "uuid": "79c0bedf29f8901ea19e54b1301851f49707a8e5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-capital-international-investors-re/brief-capital-international-investors-reports-10-3-pct-passive-stake-in-ultragenyx-idUSFWN1P50TP",
    "ord_in_thread": 0,
    "title": "BRIEF-Capital International Investors Reports 10.3 Pct Passive Stake In Ultragenyx",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 10 (Reuters) - Ultragenyx Pharmaceutical Inc:\n* CAPITAL INTERNATIONAL INVESTORS REPORTS 10.3 PERCENT PASSIVE STAKE IN ULTRAGENYX PHARMACEUTICAL INC AS OF DECEMBER 29, 2017 - SEC FILING‍​ Source text for Eikon: ( bit.ly/2D1HymY ) Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-11T06:02:00.000+02:00",
    "crawled": "2018-01-11T12:39:44.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "ultragenyx",
        "pharmaceutical",
        "inc",
        "capital",
        "international",
        "investor",
        "report",
        "percent",
        "passive",
        "stake",
        "ultragenyx",
        "pharmaceutical",
        "inc",
        "december",
        "sec",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}